Your Health. Your Family. Your Choice.
Administered by: Unknown Purchased by: ?
Life Threatening? No
Write-up: Right eye, subconjunctival hemorrhage; This is a spontaneous report from a contactable consumer (patient). A 66-year-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in Arm Right on 09Apr2021 11:00 (Lot Number: EP7533) as single dose (at the age of 66-years-old) for covid-19 immunisation. Medical history included high cholesterol, cataract surgery. Patient had no known allergies. Concomitant medications in two weeks prior to the vaccination included atorvastatin (LIPITOR). Patient did not receive other vaccine in four weeks prior to the COVID vaccine. Patient had no COVID prior vaccination. Patient was not tested for Covid post vaccination. The patient had previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, via an unspecified route of administration, administered in Left arm (Lot number: EN6206) on 17Mar2021 02:45 PM (at the age of 66-years-old) for COVID-19 immunization. The patient experienced right eye, subconjunctival hemorrhage on 11Apr2021 at 12:00. No treatment was required. Patient was recovering from the event.
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166